BioBridgeXAll companies

Pyxis Oncology, Inc.

Pharmaceutical company · Boston, Massachusetts, United States · Nasdaq: PYXS

Pyxis Oncology, Inc. is a pharmaceutical company headquartered in Boston, Massachusetts, United States. Its earliest recorded incorporation is in 2018. Its shares trade on Nasdaq under the ticker PYXS. It has reported private securities offerings to the US SEC, most recently $172 million sold in a notice filed in 2021.

Profile compiled from public records. Is this your company? Request a correction or update

Pyxis Oncology at a glance

Typepharmaceutical company
HeadquartersBoston, Massachusetts, United States
Earliest incorporation on record2018
Stock listingNasdaq: PYXS
SEC industryPharmaceutical Preparations
SEC CIK1782223

What does Pyxis Oncology do?

Private fundraising reported to the SEC

2 Form D notices; the most recent reported $172.5 million sold (2021).

Frequently asked questions about Pyxis Oncology

Where is Pyxis Oncology headquartered?

Pyxis Oncology, Inc. is headquartered in Boston, Massachusetts, United States.

What does Pyxis Oncology do?

Pyxis Oncology, Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.

Is Pyxis Oncology a public company?

Yes. Pyxis Oncology, Inc. trades on Nasdaq under the ticker PYXS.

When was Pyxis Oncology founded?

The earliest incorporation on record for Pyxis Oncology, Inc. is in 2018, according to public company registers.

Similar companies

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Sources

Location data: GeoNames (geonames.org), CC BY 4.0.

Last updated 2026-09-23.